Intermediate results of isolated mitral valve replacement with a Biocor porcine valve Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD,

Slides:

Advertisements

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study Vincent Chan,

Is individualized mitral valve repair in the future?

Endoscopic Robotic Mitral Valve Surgery

Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: Up to 21 years of clinical and echocardiographic results

Mitral mechanical replacement in young rheumatic women: Analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year.

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

William M. DeCampli, MD, PhD

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD,

Go on-pump or off-pump in diabetic patients?

Bicuspid aortic valve aortopathy: One size fits all?

Bigger The Journal of Thoracic and Cardiovascular Surgery

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Is individualized mitral valve repair in the future?

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Support Your Specialty

Quality of mitral valve surgery at the United States Department of Veterans Affairs Juan A. Crestanello, MD The Journal of Thoracic and Cardiovascular.

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Structural deterioration of the Freestyle aortic valve: Mode of presentation and mechanisms Siamak Mohammadi, MD, Richard Baillot, MD, Pierre Voisine,

Aortic valve replacement with the Mitroflow pericardial bioprosthesis: Durability results up to 21 years Charles A. Yankah, MD, PhD, Miralem Pasic, MD,

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Torsten Doenst, MD, PhD, Markus Richter, MD

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

In vitro comparison of different mechanical prostheses suitable for replacement of the systemic atrioventricular valve in children Tomaso Bottio, MD,

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Manuel J. Antunes, MD, PhD, DSc

Thirty-year experience with a bileaflet mechanical valve prosthesis

Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitation

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Antiphospholipid syndrome and right atrial mass

Warfarin or aspirin after mitral valve repair: Why work harder?

T. Brett Reece, MD The Journal of Thoracic and Cardiovascular Surgery

Hans-Joachim Schäfers, MD

Surgery for rheumatic tricuspid valve disease: A 30-year experience

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Surgical repair of congenital mitral valve malformations in infancy and childhood: A single-center 36-year experience Giovanni Stellin, MD, Massimo A.

Bicuspid aortopathy: Seeing the forest for the trees

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

“The more things change…”: The challenges ahead

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Did you like Terminator 3 better than Terminator 2

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

How do we follow up our patients

Journal changes and initiatives

Thanos Sioris, MD, Tirone E

Calpain inhibitors: The aspirin of the 21st century?

Paul Philipp Heinisch, MD, Thierry Carrel, MD

Presentation transcript:

Intermediate results of isolated mitral valve replacement with a Biocor porcine valve Giulio Rizzoli, MD, Tomaso Bottio, MD, PhD, Vladimiro Vida, MD, Georgios Nesseris, MD, Luca Caprili, MD, Gaetano Thiene, MD, Gino Gerosa, MD The Journal of Thoracic and Cardiovascular Surgery Volume 129, Issue 2, Pages 322-329 (February 2005) DOI: 10.1016/j.jtcvs.2004.06.034 Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Eight-year actuarial survival. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 322-329DOI: (10.1016/j.jtcvs.2004.06.034) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Eight-year actuarial freedom from reoperation. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 322-329DOI: (10.1016/j.jtcvs.2004.06.034) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Eight-year actual freedom from reoperation. Dotted lines depict the CI. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 322-329DOI: (10.1016/j.jtcvs.2004.06.034) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Time-related peak and mean echocardiographic gradients in patients with repeated echocardiograms. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 322-329DOI: (10.1016/j.jtcvs.2004.06.034) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Online Figure E1 Cumulative age distribution. The Journal of Thoracic and Cardiovascular Surgery 2005 129, 322-329DOI: (10.1016/j.jtcvs.2004.06.034) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions